#United States #New York #Healthcare Data #Consumer Edge #Taurus

In a groundbreaking move set to reshape the landscape of healthcare analytics, Consumer Edge has launched Taurus, a new dataset that dramatically enhances the scope of healthcare intelligence by meticulously tracking hospital purchases of medical devices and related equipment at detailed brand and model levels. This innovative product encompasses an astonishing annual purchasing spend of approximately $75 billion across around 4,500 healthcare facilities in the United States, including hospitals, ambulatory surgery centers, medical groups, and clinics.

Bill Pecoriello, CEO of Consumer Edge, emphasized the significant gap that Taurus aims to fill. "Previously, there has been no unified data source that combines both hospital purchase and claims data, leaving investors and stakeholders with critical blind spots regarding the performance of med-tech companies. With Taurus, we close that gap, providing comprehensive visibility and insight into hospital purchasing activities like never before."

Taurus is designed to provide healthcare investors with invaluable visibility into what medical devices are being procured, at what volumes, and the performance of various brands and models in the market. By integrating this hospital purchasing data with existing healthcare medical claims and pharmacy claims datasets, Taurus presents investors with an unparalleled view of healthcare demand and utilization. This comprehensive insight delivers a level of conviction and understanding previously unattainable in the market, essentially translating complex data into clear, actionable intelligence.

With the inclusion of Taurus, Consumer Edge's clients now enjoy the convenience of accessing hospital purchase data alongside healthcare claims data all within a single platform. When combined with their other products like Phoenix (pharmacy claims) and Hydrus (medical claims), Taurus provides a continuous perspective on the med-tech landscape. From device purchasing trends to procedure utilization rates, Taurus allows stakeholders to see precisely how these activities influence manufacturer revenue and overall market dynamics.

Key Features of Taurus:

• - Manufacturer-Level Analysis: One of the standout capabilities includes detailed share analysis at both the manufacturer and brand level, enabling investors to track competitive shifts within med-tech categories. This feature identifies which companies are gaining ground or losing their foothold in the market, as well as which product generations are driving adoption.
• - Performance Analytics: Taurus allows users to conduct quarterly earnings back-testing through its Dash analytics tool, where purchase trends can be examined against revenue reported by companies. This feature enables investors to validate historical performance signals and sharpen their earnings forecasts prior to results announcements.
• - Product Adoption Monitoring: As new medical devices flood the market, Taurus tracks how quickly these products gain traction. Insights can be segmented by key factors including region, facility tier, and facility type, allowing investors to get early indicators of commercial success.
• - Site-of-Care Analysis: This capability makes it easy to segment purchasing volumes by various facility types, bed sizes, and geographic locations, illuminating trends in care delivery — particularly the ongoing shift from large academic medical centers to ambulatory surgery centers and outpatient settings.
• - Robust Normalization and Adjustment: Utilizing Consumer Edge's proprietary methodology, Taurus accounts for variations due to facility network changes and invoice submission delays. This enables the isolation of true shifts in purchasing volume, ensuring the accuracy of the signals provided to users.

Consumer Edge stands as a leader in data and insights-as-a-service, specializing in consumer, B2B, and healthcare markets. Since its inception in 2009, the company has transformed data complexity into actionable insights, equipping corporate and investment leaders with superior tools for strategic decision-making. As healthcare continues to evolve, Taurus promises to be a crucial asset for stakeholders striving to navigate the intricate dynamics of medical device procurement and its implications on the industry. For an in-depth look into how Taurus can enhance your healthcare investment strategies, scheduling a demo with Consumer Edge is highly recommended.

For further inquiries, Consumer Edge encourages interested parties to get in touch for more comprehensive insights and demonstrations of this pioneering dataset.